Search

Author/Creator Clutterbuck, Elizabeth A

1. Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination. (10th December 2019)

Authors:
Wagstaffe, Helen R; Clutterbuck, Elizabeth A; Bockstal, Viki; Stoop, Jeroen N; Luhn, Kerstin; Douoguih, Macaya; Shukarev, Georgi; Snape, Matthew D; Pollard, Andrew J; Riley, Eleanor M; Goodier, Martin R
Journal:
Journal of infectious diseases
Issue:
Volume 223:Number 7(2021)
Page Start:
1171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. BCR repertoire sequencing: different patterns of B‐cell activation after two Meningococcal vaccines. Issue 10 (9th June 2015)

Authors:
Galson, Jacob D; Clutterbuck, Elizabeth A; Trück, Johannes; Ramasamy, Maheshi N; Münz, Márton; Fowler, Anna; Cerundolo, Vincenzo; Pollard, Andrew J; Lunter, Gerton; Kelly, Dominic F
Journal:
Immunology and cell biology
Issue:
Volume 93:Issue 10(2015)
Page Start:
885
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial. Issue 11 (November 2022)

Authors:
Shaw, Robert H; Liu, Xinxue; Stuart, Arabella S V; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J Claire; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Dejnirattisai, Wanwisa; Dinesh, Tanya; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; Green, Christopher A; Ha...
Journal:
Lancet
Issue:
Volume 10:Issue 11(2022)
Page Start:
1049
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Issue 10282 (10th April 2021)

Authors:
Emary, Katherine R W; Golubchik, Tanya; Aley, Parvinder K; Ariani, Cristina V; Angus, Brian; Bibi, Sagida; Blane, Beth; Bonsall, David; Cicconi, Paola; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Cox, Tony; Darton, Thomas C; Dold, Christina; Douglas, Alexander D; Duncan, Christoph...
Journal:
Lancet
Issue:
Volume 397:Issue 10282(2021)
Page Start:
1351
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants. (29th April 2020)

Authors:
Valente Pinto, Marta; O'Connor, Daniel; Galal, Ushma; Clutterbuck, Elizabeth A; Robinson, Hannah; Plested, Emma; Bibi, Sagida; Camara Pellisso, Susana; Hughes, Harri; Kerridge, Simon; Mujadidi, Yama F; Findlow, Helen; Borrow, Ray; Snape, Matthew D; Pollard, Andrew J
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 5(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Issue 10319 (1st January 2022)

Authors:
Stuart, Arabella S V; Shaw, Robert H; Liu, Xinxue; Greenland, Melanie; Aley, Parvinder K; Andrews, Nick J; Cameron, J C; Charlton, Sue; Clutterbuck, Elizabeth A; Collins, Andrea M; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J A; England, Anna; Faust, Saul N; Ferreira, Daniela M; Finn, Adam; ...
Journal:
Lancet
Issue:
Volume 399:Issue 10319(2022)
Page Start:
36
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Issue 10304 (11th September 2021)

Authors:
Flaxman, Amy; Marchevsky, Natalie G; Jenkin, Daniel; Aboagye, Jeremy; Aley, Parvinder K; Angus, Brian; Belij-Rammerstorfer, Sandra; Bibi, Sagida; Bittaye, Mustapha; Cappuccini, Federica; Cicconi, Paola; Clutterbuck, Elizabeth A; Davies, Sophie; Dejnirattisai, Wanwisa; Dold, Christina; Ewer, Katie...
Journal:
Lancet
Issue:
Volume 398:Issue 10304(2021)
Page Start:
981
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Issue 4 (April 2021)

Authors:
Pollard, Andrew J; Launay, Odile; Lelievre, Jean-Daniel; Lacabaratz, Christine; Grande, Sophie; Goldstein, Neil; Robinson, Cynthia; Gaddah, Auguste; Bockstal, Viki; Wiedemann, Aurelie; Leyssen, Maarten; Luhn, Kerstin; Richert, Laura; Bétard, Christine; Gibani, Malick M; Clutterbuck, Elizabeth A; ...
Journal:
Lancet infectious diseases
Issue:
Volume 21:Issue 4(2021)
Page Start:
493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗